Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
מצבים רפואיים
Acute Myeloid Leukemia
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
US-San Francisco CA-UCSF, San Francisco, California, United States
Contact: Study coordinator (R. Olin)US-Atlanta GA-EMORY, Atlanta, Georgia, United States
Contact: Study coordinator (W. Blum)US-Kansas City KS-KUMC, Kansas City, Kansas, United States
Contact: Study coordinator (T. Lin)US-Baltimore MD-UMGCCC, Baltimore, Maryland, United States
Contact: Study coordinator (M. Baer)US-St Louis MO-WASHU, St Louis, Missouri, United States
Contact: Study coordinator (G. Uy)US-Cincinnati OH-CINCY, Cincinnati, Ohio, United States
Contact: Study coordinator (E. Curran)AU-Adelaide-FLINDERS, Adelaide, Australia
Contact: Study coordinator (A. Beligaswatte)AU-Adelaide-RAH, Adelaide, Australia
Contact: Study coordinator (D. Hiwase)AU-Birtinya-SUNSHINECOAST, Birtinya, Australia
Contact: Study coordinator (J. Conn)AU-Brisbane-PAH, Brisbane, Australia
Contact: Study coordinator (M. Harwood)AU-Camperdown-RPA, Camperdown, Australia
Contact: Study coordinator (D. Mc Culloch)AU-Melbourne-AUSTIN, Melbourne, Australia
Contact: Study coordinator (C.Y. Fong)AU-Melbourne-PMCC, Melbourne, Australia
Contact: Study coordinator (A. Wei)AU-Sydney-WSAH, Sydney, Australia
Contact: Study coordinator (L. Vaughan)BE-Antwerpen-ZAS, Antwerp, Belgium
Contact: Study coordinator (D. Breems)Be-Charleroi-GHDC, Charleroi, Belgium
Contact: Study coordinator (V. Robin)BE-Geel-STDIMPNA, Geel, Belgium
Contact: Study coordinator (U. Douven)BE-Gent-UZGENT, Ghent, Belgium
Contact: Study coordinator (T. De Corte)BE-Haine-Saint-Paul-JOLIMONT, Jolimont, Belgium
Contact: Study coordinator (R. Lattenist)BE-Liege-CHULIEGE, Liège, Belgium
Contact: Study coordinator (A. De Voeght)BE-Liege-MONTLEGIA, Liège, Belgium
Contact: Study coordinator (Q. Perlot)BE-Yvoir-MONTGODINNE, Yvoir, Belgium
Contact: Study coordinator (E. Collinge)FI-Oulu-OYS, Oulu, Finland
Contact: Study coordinator (K. Launonen)DE-Bochum-RUB, Bochum, Germany
Contact: Study coordinator (R. Schroers)DE-Greifswald-UNIGREIFSWALD, Greifswald, Germany
Contact: Study coordinator (J. Krönke)DE-Passau-KLINIKUMPASSAU, Passau, Germany
Contact: Study coordinator (T. Suedhoff)DE-Ulm-UNIKLINKULM, Ulm, Germany
Contact: Study coordinator (H. Döhner)JP-Nagasaki Shi-NAGASAKI, Nagasaki, Japan
Contact: Study coordinator (K. Ando)NL-Amersfoort-MEANDERMC, Amersfoort, Netherlands
Contact: Study coordinator (M.F. Corsten)NL-Amsterdam-AMSTERDAMUMC, Amsterdam, Netherlands
Contact: Study coordinator (D.C. de Leeuw)NL-Amsterdam-OLVG, Amsterdam, Netherlands
Contact: Study coordinator (H. Mooij)NL-Arnhem-RIJNSTATE, Arnhem, Netherlands
Contact: Study coordinator (M. Cuipers)NL-Breda-AMPHIA, Breda, Netherlands
Contact: Study coordinator (R. Fiets)NL-Dordrecht-ASZ, Dordrecht, Netherlands
Contact: Study coordinator (P. Westerweel)NL-Eindhoven-MAXIMAMC, Eindhoven, Netherlands
Contact: Study coordinator (L. Tick)NL-Groningen-UMCG, Groningen, Netherlands
Contact: Study coordinator (G. Huls)NL-Leeuwarden-FRISIUSMC, Leeuwarden, Netherlands
Contact: Study coordinator (B. Franken)NL-Leiden-LUMC, Leiden, Netherlands
Contact: Study coordinator (J.H. Veelken)NL-Nieuwegein-ANTONIUS, Nieuwegein, Netherlands
Contact: Study coordinator (M. Söhne)NL-Nijmegen-RADBOUD, Nijmegen, Netherlands
Contact: Study coordinator (F. in 't Hout)NL-Rotterdam-ERASMUCMC, Rotterdam, Netherlands
Contact: Study coordinator (M.H.G. Raaijmakers)NL-Den Haag-HAGA, The Hague, Netherlands
Contact: Study coordinator (D. Lammeren, van-Venema)SE-Lund-Suh, Lund, Sweden
Contact: Study coordinator (V. Lazarevic)
מובילי המחקר
M.H.G.P. Raaijmakers
Principal Investigator
Erasmus Medical Center